BioSpace News Archive

Halberd Corporation (OTC Pink: HALB) announced the formation of Halberd Cancer Therapeutics, LTD, as a wholly owned subsidiary.

Yuyu Pharma announces the enrollment of the first patient in a phase 2 clinical study evaluating YP-P10, a novel and patented synthetic peptide with anti-inflammatory and wound healing properties to treat patients with dry eye disease (DED).

The requested amendment and extension is subject to approval from the Exchange.

New York University Langone Health is considered one of the top ten hospitals in the country with 539 locations throughout New York, New Jersey, and Florida.

Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s and Children’s Hospital in Singapore evaluated the ability of electroencephalogram (EEG)-guided anesthesia, using Masimo SedLine® brain function monitoring, to reduce the amount of the drug sevoflurane needed to maintain anesthesia in pediatric patients undergoing minor surgery.

Specialty cancer diagnostics company Precipio, Inc., announced that it has entered into an agreement with Fisher Healthcare, a part of Thermo Fisher Scientific to distribute its proprietary HemeScreen assays to its customers.

Olympus Corporation of the Americas, a leading medical technology company, scored 90 out of 100 in its inaugural inclusion on Disability:IN’s 2022 Disability Equality Index, a comprehensive tool that helps companies work toward disability inclusion.

Constant Therapy Health, a brain health digital therapeutics company, announced today the publication of a dosage study in the Journal of Medical Internet Research entitled, “Dosage Frequency Effects on Treatment Outcomes Following Self-managed Digital Therapy: Retrospective Cohort Study”.

The report consists of quantitative and qualitative research on the market performed by our market experts.

Forecast to 2030,’ thoroughly examines the Bronchiolitis industry to provide essential data & information for the targeted readers.